Nursing Elites

1. What is a condition where the heart beats too fast, reducing its ability to pump blood effectively?

• A. Tachycardia
• B. Bradycardia
• C. Arrhythmia
• D. Ventricular fibrillation

Correct answer: A

Rationale: Tachycardia is the correct answer because it is a condition characterized by a fast heart rate, which can decrease the heart's efficiency in pumping blood. Bradycardia, on the other hand, refers to a slow heart rate, which is the opposite of what is described in the question. Arrhythmia is a general term for any irregularity in the heart's rhythm, not necessarily specifically related to a fast heart rate. Ventricular fibrillation is a life-threatening arrhythmia where the heart's lower chambers quiver instead of pumping blood effectively, but it is not specifically characterized by a fast heart rate.

2. Which of the following is a chronic respiratory disease characterized by the irreversible obstruction of airflow?

• A. Chronic obstructive pulmonary disease (COPD)
• B. Asthma
• C. Pulmonary edema
• D. Bronchiectasis

Correct answer: A

Rationale: The correct answer is A, Chronic obstructive pulmonary disease (COPD). COPD is a chronic respiratory disease where the airflow in the lungs becomes obstructed, making it difficult to breathe. Choice B, Asthma, is a different chronic respiratory condition characterized by reversible airflow obstruction and airway hyperresponsiveness. Choice C, Pulmonary edema, is a condition where fluid accumulates in the lungs, leading to difficulty in breathing but not irreversible airflow obstruction. Choice D, Bronchiectasis, is a condition characterized by abnormal widening of the bronchial tubes, leading to recurrent respiratory infections, but it is not specifically defined by irreversible airflow obstruction.

3. Which condition is characterized by chronic inflammation of the airways resulting in excess mucus production, leading to frequent coughing and breathing difficulties?

• A. Chronic bronchitis
• B. Asthma
• C. Pneumonia
• D. COPD

Correct answer: A

Rationale: The correct answer is A, Chronic bronchitis. Chronic bronchitis involves long-term inflammation of the bronchi, leading to excessive mucus production, frequent coughing, and breathing difficulties. Asthma (B) is characterized by reversible airway obstruction and bronchospasms. Pneumonia (C) is an infection of the lungs caused by bacteria, viruses, or fungi. COPD (D) is a term used to describe chronic lung diseases that cause airflow blockage and breathing-related problems.

4. Which term refers to the contraction phase of the heart when blood is ejected from the chambers?

• A. Systole
• B. Diastole
• C. Contractility
• D. Afterload

Correct answer: A

Rationale: The correct answer is A, systole. Systole is the phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. During diastole (choice B), the heart relaxes and fills with blood, contrasting with systole. Contractility (choice C) refers to the ability of the heart to contract effectively. Afterload (choice D) is the pressure the heart must work against to eject blood during systole.

5. The client on spironolactone (Aldactone) has a potassium level of 5.6 mEq/L. What is the nurse’s priority action?

• A. Hold the spironolactone and notify the healthcare provider.
• B. Administer potassium supplements.
• C. Continue the spironolactone as ordered.
• D. Increase the dose of spironolactone.

Correct answer: A

Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.6 mEq/L is high, indicating hyperkalemia. Spironolactone is a potassium-sparing diuretic that can further elevate potassium levels. Therefore, the priority action is to withhold the medication to prevent exacerbating hyperkalemia and notify the healthcare provider for further management. Option B is incorrect because administering potassium supplements would worsen the hyperkalemia. Option C is incorrect as continuing spironolactone can lead to a further increase in potassium levels. Option D is incorrect as increasing the dose of spironolactone would be inappropriate in the presence of elevated potassium levels.

Similar Questions